Replies to post #142060 on Innovation Pharmaceuticals Inc (IPIX)

[NotRichYet2]

DISAGREE - They should and are proceeding with the PHASE trials which take time. One either believes in the science being done at CTIX or not. Everything else is pure useless NOISE.

[TheDane]

THAT'S WHAT I'VE BEEN SAYING!!!! Leo isn't listening.

[MinnieM]

A lot has happened clinically in the past 1½ years since this, your first post here on 03/15/16. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121215320

Management appears to have been very busy. Here's a rough list:

https://clinicaltrials.gov/ct2/results?term=cellceutix

ph2b prurisol Psoriasis trial, first received on clinicaltrials.gov on 10.14.16

ph2a kevetrin Ovarian Cancer trial, first received on clinicaltrials.gov on 2.1.17

and, a ph2 PoC brilacidin IBD: UC (UP/UPS) trial outside the US. Results can be seen here: http://www.ipharminc.com/press-release/2017/7/13/innovation-pharmaceuticals-phase-2-poc-trial-for-inflammatory-bowel-disease-achieves-induction-of-remission-in-a-majority-of-patients-treated-with-brilacidin

The brilacidin ph2 Oral Mucositis trial gave interim results on 3.27.17 http://www.ipharminc.com/press-release/2017/3/27/cellceutix-reports-very-encouraging-interim-analysis-of-phase-2-drug-candidate-brilacidin-for-severe-oral-mucositis-om-in-head-and-neck-cancer-patients-high-potential-for-preventative-treatment

Anticipated upcoming events with my timeline guestimate:

My new expectations are for the brilacidin ph2 Oral Mucositis trial to give topline results in late Oct or mid Nov 2017.

My expectations for topline results on the prurisol ph2b Psoriasis trial are from Nov/Dec 2017.

The kevetrin ph2a Ovarian Cancer trial may give some sort of readout in Dec 2017.





In Reply to 'MXAMDUD'
Another day of horrific price action. these bums should defend their stock by actually buying it in the open market

[MinnieM]

A lot has happened clinically in the past 1½ years since this, your first post here on 03/15/16. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121215320

Management appears to have been very busy. Here's a rough list:

https://clinicaltrials.gov/ct2/results?term=cellceutix

ph2b prurisol Psoriasis trial, first received on clinicaltrials.gov on 10.14.16

ph2a kevetrin Ovarian Cancer trial, first received on clinicaltrials.gov on 2.1.17

and, a ph2 PoC brilacidin IBD: UC (UP/UPS) trial outside the US. Results can be seen here: http://www.ipharminc.com/press-release/2017/7/13/innovation-pharmaceuticals-phase-2-poc-trial-for-inflammatory-bowel-disease-achieves-induction-of-remission-in-a-majority-of-patients-treated-with-brilacidin

The brilacidin ph2 Oral Mucositis trial gave interim results on 3.27.17 http://www.ipharminc.com/press-release/2017/3/27/cellceutix-reports-very-encouraging-interim-analysis-of-phase-2-drug-candidate-brilacidin-for-severe-oral-mucositis-om-in-head-and-neck-cancer-patients-high-potential-for-preventative-treatment

Anticipated upcoming events with my timeline guestimate:

My expectations are for the brilacidin ph2 Oral Mucositis trial to give topline results in late Oct or mid Nov 2017.

My expectations for topline results on the prurisol ph2b Psoriasis trial are anticipated for around Dec 2017.

The kevetrin ph2a Ovarian Cancer trial may give some sort of readout in Dec 2017.





In Reply to 'MXAMDUD' first ihub post on this board:

Another day of horrific price action. these bums should defend their stock by actually buying it in the open market